David Chadwick MP: written questions
David Chadwick MP: full overview
4 Jul 2024–3 Jul 2025
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 21 Nov 2026
- Last successful import
- 21 Nov 2026
- Records dated through
- 20 Nov 2026
- Selected period
- Reporting year 1: 4 Jul 2024 to 3 Jul 2025
- Completeness
- Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
7 published records · newest first.
Written questions
Oxygen: Medical TreatmentsDepartment of Health and Social CareTabled 30 May 2025AnsweredUIN 55913More
Question: To ask the Secretary of State for Health and Social Care, with reference to NHS England awarding contracts for Hyperbaric Oxygen Therapy (HBOT) services to three of six planned regional centres, if she will undertake a review of NHS England's recompressio
Answer: We are committed to ensuring equitably accessible, high-quality services, for any patient who requires Hyperbaric Oxygen Therapy. NHS England set out their assessment of service requirements in their commissioning intentions during the public consultation...
Answered 12 Jun 2025
Original Parliament recordCoronavirus: DrugsDepartment of Health and Social CareTabled 18 Mar 2025AnsweredUIN 39290More
Question: To ask the Secretary of State for Health and Social Care, whether he has had discussions with NICE on the potential use of PEMGARDA to protect clinically vulnerable people against covid-19 in emergency situations.
Answer: It is critical that medicines used in the United Kingdom are safe and effective and as such, medicines cannot be marketed in the UK without a marketing authorisation. These are granted by the Medicines and Healthcare products Regulatory Agency (MHRA) whic...
Answered 26 Mar 2025
Original Parliament recordAlzheimer's Disease: ResearchDepartment of Health and Social CareTabled 28 Feb 2025AnsweredUIN 34725More
Question: To ask the Secretary of State for Health and Social Care, what steps the Government is taking to support ongoing research into Alzeimher's.
Answer: The Government’s responsibility for delivering research into Alzheimer’s disease is shared between the Department of Health and Social Care, with research delivered via the National Institute for Health and Care Research (NIHR), and the Department for Sci...
Answered 11 Mar 2025
Original Parliament recordHealth: WomenDepartment of Health and Social CareTabled 10 Feb 2025AnsweredUIN 30371More
Question: To ask the Secretary of State for Health and Social Care, what steps the Government is taking to ensure that female-only medical conditions are included in medical training and research.
Answer: The General Medical Council (GMC) sets and enforces the standards that all doctors, Anaesthesia Associates, and Physician Associates must adhere to. The standard of training for doctors is the responsibility of the GMC, who set the outcome standards expec...
Answered 14 Feb 2025
Original Parliament recordPancreatic Enzyme Replacement Therapy: ShortagesDepartment of Health and Social CareTabled 23 Jan 2025AnsweredUIN 26253More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential economic impact of seeking unlicensed products as an alternative to Creon to mitigate ongoing pancreatic enzyme replacement therapy shortages on pharmac
Answer: There has been no assessment on the potential economic impact of seeking unlicensed products as an alternative to Creon.The Department is continuing to engage with suppliers of pancreatic enzyme replacement therapy (PERT) and special importers of unlicens...
Answered 30 Jan 2025
Original Parliament recordHospitals: FoodDepartment of Health and Social CareTabled 12 Dec 2024AnsweredUIN 19884More
Question: To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effect of access to nutritious, appetising hospital food on patient's health, recovery and time spent in hospital; and what plans he has to introduce policies t
Answer: The Independent Review of Hospital Food, applicable to hospitals in England only, and published in October 2020, made a suite of recommendations for improving hospital food. The review made clear the positive effect on patient recovery and wellbeing of ac...
Answered 18 Dec 2024
Original Parliament recordCoronavirus: ImmunosuppressionDepartment of Health and Social CareTabled 4 Oct 2024AnsweredUIN 7225More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that immunocompromised people with conditions that render them more vulnerable to covid-19 have timely access to effective (a) protective drugs and (b) support mea
Answer: Since June 2023, the pathway for COVID-19 treatments has been delegated from the former national pandemic-specific arrangements to more routine local arrangements for assessment and treatment. Integrated care boards are now responsible for ensuring that l...
Answered 14 Oct 2024
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2024–3 Jul 2025. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →